Chronic kidney disease and pregnancy: an interdisciplinary assessment of gestational risks and complications. A literature review

Abstract

Chronic kidney disease represents a heterogeneous group of diseases characterized by changes in the kidneys’ structure and functions. It significantly increases the risks of adverse maternal and perinatal outcomes. These risks increase with worsening renal dysfunction corresponding to an increase in the degree of proteinuria and arterial hypertension. Anatomical and physiological changes in the kidneys during pregnancy are characterized by dilatation of the pelvicalyceal system, a decrease in systemic and renal vascular resistance, and an increase in the glomerular filtration rate. These clinically significant changes can complicate the diagnosis of the renal dysfunction, as well as its progression. Pregnancy can affect the kidney as it can manifest as declining kidney function, especially in the context of concomitant arterial hypertension and proteinuria, while chronic kidney disease, regardless of the stage, contributes to a higher risk of adverse pregnancy outcomes including preeclampsia, premature birth and fetal growth restriction.

Optimization strategies of pregnancy outcomes include strict control of blood pressure, treatment of hypertension and proteinuria, and prevention of preeclampsia. The latter is difficult to diagnose in pregnant women with chronic kidney disease. Serum markers such as soluble fms-like tyrosine kinase 1 and placental growth factor may aid in definitive diagnosis. The choice of delivery mode in women with chronic kidney disease should be based on common obstetric indications. A multidisciplinary team, including an obstetrician-gynecologist, a nephrologist, an anaesthesiologist and a neonatologist, must focus on preconception medical care, antenatal care and treatment of pregnant women with chronic kidney disease for a successful pregnancy outcome.

Keywords

chronic kidney disease / pregnancy / preeclampsia / extragenital diseases

References

[1] Khronicheskaya bolezn’ pochek (KhBP). Klinicheskie rekomendatsii / Assotsiatsiya nefrologov; MZ RF. Moskva, 2021 [cited 2022 Dec 12]. Available from: https://base.garant.ru/403721488/

[2] Хроническая болезнь почек (ХБП). Клинические рекомендации / Ассоциация нефрологов; МЗ РФ. Москва, 2021 [дата обращения 12.12.2022]. Доступ по ссылке: https://base.garant.ru/403721488/

[3] Nikol’skaya I.G. Beremennost’ i khronicheskaya bolezn’ pochek: gestatsionnye oslozhneniya, materinskie i perinatal’nye iskhody [dissertation]. Moscow; 2019 [cited 2022 Dec 12]. Available from: https://www.dissercat.com/content/beremennost-i-khronicheskaya-bolezn-pochek-gestatsionnye-oslozhneniya-materinskie-i-perinata

[4] Никольская И.Г. Беременность и хроническая болезнь почек: гестационные осложнения, материнские и перинатальные исходы: диc. ... д-ра мед. наук. Москва, 2019 [дата обращения 12.12.2022]. Доступ по ссылке: https://www.dissercat.com/content/beremennost-i-khronicheskaya-bolezn-pochek-gestatsionnye-oslozhneniya-materinskie-i-perinata

[5] Jesudason S, Tong A. The patient experience of kidney disease and pregnancy. Best Pract Res Clin Obstet Gynaecol. 2019;57:77–88. DOI: 10.1016/j.bpobgyn.2018.12.003

[6] Jesudason S., Tong A. The patient experience of kidney disease and pregnancy // Best. Pract. Res. Clin. Obstet. Gynaecol. 2019. Vol. 57. P. 77–88. DOI: 10.1016/j.bpobgyn.2018.12.003

[7] Temirbulatov RR, Bezhenar VF, Reznik ON, et al. Pregnancy and childbirth in patients with renal allograft. The Scientific Notes of the Pavlov University. 2017;24(1):74–78. (In Russ.). DOI: 10.24884/1607-4181-2017-24-1-74-78

[8] Темирбулатов Р.Р., Беженарь В.Ф., Резник О.Н., и др. Беременность и роды у пациенток с почечным аллотрансплантатом // Ученые записки Первого Санкт-Петербургского государственного медицинского университета имени академика И.П. Павлова. 2017. Т. 24. № 1. С. 74–78. DOI: 10.24884/1607-4181-2017-24-1-74-78

[9] Krouwel EM, Nicolai MPJ. What is the role of nephrologists and nurses of the dialysis department in providing fertility care to CKD patients? A questionnaire study among care providers. Int Urol Nephrol. 2017;49(7):1273–1285. DOI: 10.1007/s11255-017-1577-z

[10] Krouwel E.M., Nicolai M.P.J. What is the role of nephrologists and nurses of the dialysis department in providing fertility care to CKD patients? A questionnaire study among care providers // Int. Urol. Nephrol. 2017. Vol. 49. No. 7. P. 1273–1285. DOI: 10.1007/s11255-017-1577-z

[11] Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease — a systematic review and meta-analysis. Plos One. 2016;11(7):1–18. DOI: 10.1371/journal.pone.0158765

[12] Hill N.R., Fatoba S.T., Oke J.L., et al. Global prevalence of chronic kidney disease — a systematic review and meta-analysis // Plos One. 2016. Vol. 11. No. 7. P. 1–18. DOI: 10.1371/journal.pone.0158765

[13] GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. DOI: 10.1016/S0140-6736(20)30045-3

[14] GBD chronic kidney disease collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 // Lancet. 2020. Vol. 395. No. 10225. P. 709–733. DOI: 10.1016/S0140-6736(20)30045-3

[15] Piccoli GB, Cabiddu G. Pregnancy and kidney disease: from medicine based on exceptions to exceptional medicine. J Nephrol. 2017;30(3):303–305. DOI: 10.1007/s40620-017-0399-5.

[16] Piccoli G.B., Cabiddu G. Pregnancy and kidney disease: from medicine based on exceptions to exceptional medicine // J. Nephrol. 2017. Vol. 30. No. 3. P. 303–305. DOI: 10.1007/s40620-017-0399-5

[17] Reynolds ML, Herrera CА. Chronic kidney disease and pregnancy. Adv Chronic Kidney Dis. 2020;27(6):461–468. DOI: 10.1053/j.ackd.2020.04.003

[18] Reynolds M.L., Herrera C.А. Chronic kidney disease and pregnancy // Adv. Chronic. Kidney Dis. 2020. Vol. 27. No. 6. P. 461–468. DOI: 10.1053/j.ackd.2020.04.003

[19] Maule SP, Danielle CА, Hannah B, et al. CKD and pregnancy outcomes in Africa: a narrative review. Kidney Int Rep. 2020;5(8):1342–1349. DOI: 10.1016/j.ekir.2020.05.016

[20] Maule S.P., Danielle C.А., Hannah B., et al. CKD and pregnancy outcomes in Africa: a narrative review // Kidney Int Rep. 2020. Vol. 5. No. 8. P. 1342–1349. DOI: 10.1016/j.ekir.2020.05.016

[21] Lindheimer MD, Davison JM. Pregnancy and the kidney: managing hypertension and renal disease during gestation. Nephrology Self Assess Program. 2016;(15):109–114.

[22] Lindheimer M.D., Davison J.M. Pregnancy and the kidney: managing hypertension and renal disease during gestation // Nephrology Self Assess Program 2016. No. 15. P. 109–114.

[23] Tetelyutina FK, Chernenkova ML. Peculiarities of birth activity in women with chronic pyelonephritis. Prakticheskaya medicina. 2017;7(108):67–71.

[24] Тетелютина Ф.К., Черненкова М.Л. Особенности родовой деятельности у женщин с хроническим пиелонефритом // Практическая медицина. 2017. Т. 7. № 108. С. 67–71.

[25] Putinceva AD, Zhdanova IV, Lavrinovich OE, et al. Case of pregnancy favorable outcome in a patient receiving hemodialysis therapy. Case report. Nefrologiya i dializ. 2017;19(4):531–539. DOI: 10.28996/1680-4422-2017-4-531-539

[26] Путинцева А.Д., Жданова И.В., Лавринович О.Е., и др. Случай благополучного исхода беременности у пациентки, получающей терапию программным гемодиализом. Наблюдение из практики // Нефрология и диализ. 2017. Т. 19. № 4. С. 531–539. DOI: 10.28996/1680-4422-2017-4-531-539

[27] Wiles KS, Nelson-Piercy C, Bramham K. Reproductive health and pregnancy in women with chronic kidney disease. Nature reviews. Nephrology. 2018;14(3):165–184. DOI: 10.1038/nrneph.2017.187

[28] Wiles K.S., Nelson-Piercy C., Bramham K. Reproductive health and pregnancy in women with chronic kidney disease // Nature reviews. Nephrology. 2018. Vol. 14. No. 3. P. 165–184. DOI: 10.1038/nrneph.2017.187

[29] Piccoli GB, Zakharova E. Pregnancy in chronic kidney disease: need for higher awareness. a pragmatic review focused on what could be improved in the different CKD stages and phases. J Clin Med. 2018;7(11):1–21. DOI: 10.3390/jcm7110415

[30] Piccoli G.B., Zakharova E. Pregnancy in chronic kidney disease: need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases // J. Clin. Med. 2018. Vol. 7. No. 11. P. 1–21. DOI: 10.3390/jcm7110415

[31] Zhang J-J, Ma X-X, Hao L, et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin J Am Soc Nephrol. 2015;10(11):1964–1978. DOI: 10.2215/CJN.09250914

[32] Zhang J.-J., Ma X.-X., Hao L., et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy // Clin. J. Am. Soc. Nephrol. 2015. Vol. 10. No. 11. P. 1964–1978. DOI: 10.2215/CJN.09250914

[33] Sukainah Al Khalaf, Bodunde Е, Gillian MM, et al. Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226(5):656–670. DOI: 10.1016/j.ajog.2021.10.037

[34] Sukainah A.l. Khalaf, Bodunde Е., Gillian M.M., et al. Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis // Am. J. Obstet. Gynecol. 2022. Vol. 226. No. 5. P. 656–670. DOI: 10.1016/j.ajog.2021.10.037

[35] Temirbulatov RR, Bezhenar VF, Smirnov AV. Differential diagnostics of preeclampsia in patients with chronic kidney disease. Nephrology. 2019;23(1):45–50. (In Russ.) DOI: 10.24884/1561-6274-2019-23-1-45-50

[36] Темирбулатов Р.P., Беженарь В.Ф., Смирнов A.В. Дифференциальная диагностика преэклампсии у пациенток с хронической болезнью почек // Нефрология. 2019. Т. 23. № 1. С. 45–50. DOI: 10.24884/1561-6274-2019-23-1-45-50

[37] Bramham K, Seed PT, Lightstone L, et al. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney International. 2016;89(4):874–885. DOI: 10.1016/j.kint.2015.10.012

[38] Bramham K., Seed P.T., Lightstone L., et al. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease // Kidney International. 2016. Vol. 89. No. 4. P. 874–885. DOI: 10.1016/j.kint.2015.10.012

[39] Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43. DOI: 10.1161/HYPERTENSIONAHA.117.10803

[40] Brown M.A., Magee L.A., Kenny L.C., et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice // Hypertension. 2018. Vol. 72. No. 1. P. 24–43. DOI: 10.1161/HYPERTENSIONAHA.117.10803

[41] Wiles K, Bramham K, Seed PT, et al. Diagnostic indicators of superimposed preeclampsia in women with CKD. Kidney Int Rep. 2019;4(6):842–853. DOI: 10.1016/j.ekir.2019.03.012

[42] Wiles K., Bramham K., Seed P.T., et al. Diagnostic indicators of superimposed preeclampsia in women with CKD // Kidney Int. Rep. 2019. Vol. 4. No. 6. P. 842–853. DOI: 10.1016/j.ekir.2019.03.012

[43] Wiles K, Chappel LC, Lightstone L, et al. Updates in diagnosis and management of preeclampsia in women with CKD. Clin J Am Soc Nephrol. 2020;15(9):1371–1380. DOI: 10.2215/CJN.15121219.

[44] Wiles K., Chappel L.C., Lightstone L., et al. Updates in diagnosis and management of preeclampsia in women with CKD // Clin. J. Am. Soc. Nephrol. 2020. Vol. 15. No. 9. P. 1371–1380. DOI: 10.2215/CJN.15121219

[45] Hall DR, Conti-Ramsden F. Acute kidney injury in pregnancy including renal disease diagnosed in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2019;(57):47–59. DOI: 10.1016/j.bpobgyn.2018.12.005

[46] Hall D.R., Conti-Ramsden F. Acute kidney injury in pregnancy including renal disease diagnosed in pregnancy // Best Pract. Res. Clin. Obstet. Gynaecol. 2019. Vol. 57. P. 47–59. DOI: 10.1016/j.bpobgyn.2018.12.005

[47] Wiles K, Chappell L, Clark K, et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrology. 2019;20(1):1–43. DOI: 10.1186/s12882-019-1560-2

[48] Wiles K., Chappell L., Clark K. et al. Clinical practice guideline on pregnancy and renal disease // BMC Nephrology. 2019. Vol. 20. No. 1. P. 1–43. DOI: 10.1186/s12882-019-1560-2

[49] Wiles K, Oliveira L. Dialysis in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2019;(57):33–46. DOI: 10.1016/j.bpobgyn.2018.11.007

[50] Wiles K., Oliveira L. Dialysis in pregnancy // Best Pract. Res. Clin. Obstet. Gynaecol. 2019. Vol. 57. P. 33–46. DOI: 10.1016/j.bpobgyn.2018.11.007

[51] Bezhenar’ VF, Smirnov AV, Temirbulatov RR. Renal dysfunction in preeclampsia: prognosis and differential diagnosis. Part 1. Doktor.Ru. 2020;19(6):23–29. (In Russ.). DOI: 10.31550/1727-2378-2020-19-6-23-29

[52] Беженарь В.Ф., Смирнов А.В., Темирбулатов Р.Р., и др. Почечная дисфункция при преэклампсии: прогнозирование и дифференциальный диагноз. Часть 1 // Доктор.Ру. 2020. Т. 19. № 6. С. 23–29. DOI: 10.31550/1727-2378-2020-19-6-23-29

[53] Bezhenar’ VF, Smirnov AV, Temirbulatov RR. Renal dysfunction in preeclampsia: prognosis and differential diagnosis. Part 2. Doktor.Ru. 2020;19(8):7–13. (In Russ.). DOI: 10.31550/1727-2378-2020-19-8-7-13

[54] Беженарь В.Ф., Смирнов А.В., Темирбулатов Р.Р. и др. Почечная дисфункция при преэклампсии: прогнозирование и дифференциальный диагноз. Часть 2 // Доктор.Ру. 2020. Т. 19. № 8. С. 7–13. DOI: 10.31550/1727-2378-2020-19-8-7-13

[55] Padberg JS, Wiesinger A, di Marco GS, et al. Damage of the endothelial glycocalyx in chronic kidney disease. Atherosclerosis. 2014;234(2):335–343. DOI: 10.1016/j.atherosclerosis.2014.03.016

[56] Padberg J.S., Wiesinger A., di Marco G.S., et al. Damage of the endothelial glycocalyx in chronic kidney disease // Atherosclerosis. 2014. Vol. 234. No. 2. P. 335–343. DOI: 10.1016/j.atherosclerosis.2014.03.016

[57] Weissgerber TL, Garcia-Valencia O, Milic NM, et al. Early onset preeclampsia is associated with glycocalyx degradation and reduced microvascular perfusion. J Am Heart Assoc. 2019;8(4):106–147. DOI: 10.1161/JAHA.118.010647.

[58] Weissgerber T.L., Garcia-Valencia O., Milic N.M., et al. Early onset preeclampsia is associated with glycocalyx degradation and reduced microvascular perfusion // J. Am. Heart Assoc. 2019. Vol. 8. No. 4. P. 106–147. DOI: 10.1161/JAHA.118.010647

[59] Gonzalez Suarez ML, Kattah A, Grande JP, et al. Renal disorders in pregnancy: core curriculum. Am J Kidney Dis. 2019;73(1):119–130. DOI: 10.1053/j.ajkd.2018.06.006

[60] Gonzalez Suarez M.L., Kattah A., Grande J.P., et al. Renal disorders in pregnancy: core curriculum // Am. J. Kidney Dis. 2019. Vol. 73. No. 1. P. 119–130. DOI: 10.1053/j.ajkd.2018.06.006

[61] Magee LA, Dadelszen PV. State-of-the-art diagnosis and treatment of hypertension in pregnancy. Mayo Clinic Proceedings. 2018;93(11):1664–1677. DOI: 10.1016/j.mayocp.2018.04.033

[62] Magee L.A., Dadelszen P.V. State-of-the-art diagnosis and treatment of hypertension in pregnancy // Mayo Clinic Proceedings. 2018. Vol. 93. No. 11. P. 1664–1677. DOI: 10.1016/j.mayocp.2018.04.033

[63] Thadhani R, Hagmann H, Schaarschmidt W, et al. Removal of soluble FMS-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol. 2016;27(3): 903–913. DOI: 10.1681/ASN.2015020157

[64] Thadhani R., Hagmann H., Schaarschmidt W., et al. Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia // J. Am. Soc. Nephrol. 2016. Vol. 27. No. 3. P. 903–913. DOI: 10.1681/ASN.2015020157

[65] Roberge S, Nicolaides K, Demers S, et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(2):110–120. DOI: 10.1016/j.ajog.2016.09.076

[66] Roberge S., Nicolaides K., Demers S., et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis // Am. J. Obstet. Gynecol. 2017. Vol. 216. No. 2. P. 110–120. DOI: 10.1016/j.ajog.2016.09.076

[67] Meher S, Duley L, Hunter K. Antiplatelet therapy before or after 16 weeks’ gestation for preventing preeclampsia: an individual participant data meta-analysis. Am J Obstet. Gynecol. 2017;216(2):121–128. DOI: 10.1016/j.ajog.2016.10.016

[68] Meher S., Duley L., Hunter K. Antiplatelet therapy before or after 16 weeks’ gestation for preventing preeclampsia: an individual participant data meta-analysis. // Am. J. Obstet. Gynecol. 2017. Vol. 216. No. 2. P. 121–128. DOI: 10.1016/j.ajog.2016.10.016

[69] National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management. London: NICE Guideline; 2019.

[70] National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management. London: NICE Guideline, 2019.

[71] Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613–622. DOI: 10.1056/NEJMoa1704559.

[72] Rolnik D.L., Wright D., Poon L.C., et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia // N. Engl. J. Med. 2017. Vol. 377, No. 7. P. 613–622. DOI: 10.1056/NEJMoa1704559

[73] Guida JP, Parpinelli MA, Surita FG, et al. The impact of proteinuria on maternal and perinatal outcomes among women with pre-eclampsia. Int. J. Gynaecol. Obstet. 2018;143(1):101–117. DOI: 10.1002/ijgo.12487

[74] Guida J.P., Parpinelli M.A., Surita F.G., et al. The impact of proteinuria on maternal and perinatal outcomes among women with pre-eclampsia // Int. J. Gynaecol. Obstet. 2018. Vol. 143. No. 1. P. 101–117. DOI: 10.1002/ijgo.12487

[75] Mateus J, Newman R, Sibai BM, et al. Massive urinary protein excretion associated with greater neonatal risk in preeclampsia. AJP Reports. 2017;7(1):49–58. DOI: 10.1055/s-0037-1601866

[76] Mateus J., Newman R., Sibai B.M., et al. Massive urinary protein excretion associated with greater neonatal risk in preeclampsia // AJP Reports. 2017. Vol. 7. No. 1. P. 49–58. DOI: 10.1055/s-0037-1601866

[77] Kim MJ, Kim YN, Jung EJ, et al. Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia? Obstet Gynecol Sci. 2017;60(3):260–265. DOI: 10.5468/ogs.2017.60.3.260

[78] Kim M.J., Kim Y.N., Jung E.J., et al. Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia? // Obstet. Gynecol. Sci. 2017. Vol. 60, No. 3. P. 260–265. DOI: 10.5468/ogs.2017.60.3.260

[79] Li B, Lin L, Yang H, et al. The value of the 24-h proteinuria in evaluating the severity of preeclampsia and predicting its adverse maternal outcomes. Hypertens Pregnancy. 2018;37(3):118–125. DOI: 10.1080/10641955.2018.1487564

[80] Li B., Lin L., Yang H., et al. The value of the 24-h proteinuria in evaluating the severity of preeclampsia and predicting its adverse maternal outcomes // Hypertens. Pregnancy. 2018. Vol. 37. No. 3. P. 118–125. DOI: 10.1080/10641955.2018.1487564

[81] American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. Gestational hypertension and preeclampsia: ACOG practice bulletin No. 222. Obstet Gynecol. 2020;135(6):237–260. DOI: 10.1097/AOG.0000000000003891

[82] American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins Obstetrics. Gestational hypertension and preeclampsia: ACOG Practice Bulletin No. 222 // Obstet. Gynecol. 2020. Vol. 135. No. 6. P. 237–260. DOI: 10.1097/AOG.0000000000003891

[83] Confortini PG, Galanti G, Ancona G, et al. Full term pregnancy and successful delivery in a patient on chronic haemodialysis. Proc Eur Dial Transplant Assoc. 1971;8:74–80.

[84] Confortini P.G., Galanti G., Ancona G., et al. Full term pregnancy and successful delivery in a patient on chronic haemodialysis // Proc. Eur. Dial. Transplant. Assoc. 1971. Vol. 8. P. 74–80.

[85] Okundaye I, Abrinko P, Hou S. Registry of pregnancy in dialysis patients. Am J Kidney Dis. 1998; 31(5):766–773. DOI: 10.1016/s0272-6386(98)70044-7

[86] Okundaye I., Abrinko P., Hou S. Registry of pregnancy in dialysis patients // Am. J. Kidney Dis. 1998. Vol. 31. No. 5. P. 766–773. DOI: 10.1016/s0272-6386(98)70044-7

[87] Toma H, Tanabe K, Tokumoto T, et al. Pregnancy in women receiving renal dialysis or transplantation in Japan: a nationwide survey. Nephrol Dialys Transplant. 1999;14(6):1511–1516. DOI: 10.1093/ndt/14.6.1511

[88] Toma H., Tanabe K., Tokumoto T., et al. Pregnancy in women receiving renal dialysis or transplantation in Japan: a nationwide survey // Nephrol Dial Transplant. 1999. Vol. 14. No. 6. P. 1511–1516. DOI: 10.1093/ndt/14.6.1511

[89] Souqiyyeh MZ, Huraib SO, Saleh AG, et al. Pregnancy in chronic hemodialysis patients in the Kingdom of Saudi Arabia. Am. J. Kidney Dis. 1992;19(3):235–238. DOI: 10.1016/s0272-6386(13)80003-0

[90] Souqiyyeh M.Z., Huraib S.O., Saleh A.G., et al. Pregnancy in chronic hemodialysis patients in the Kingdom of Saudi Arabia // Am. J. Kidney Dis. 1992. Vol. 19. No. 3. P. 235–238. DOI: 10.1016/s0272-6386(13)80003-0

[91] Shah S, Christianson AL, Meganathan K, et al. Racial differences and factors associated with pregnancy in ESKD patients on dialysis in the United States. J Am Soc Nephrol. 2019;30(12):2437–2448. DOI: 10.1681/ASN.2019030234.

[92] Shah S., Christianson A.L., Meganathan K., et al. Racial differences and factors associated with pregnancy in ESKD patients on dialysis in the United States // J. Am. Soc. Nephrol. 2019. Vol. 30. No. 12. P. 2437–2448. DOI: 10.1681/ASN.2019030234

[93] Oliverio AL, Admon LK, Mariani LH, et al. Health outcomes and health care utilization among obstetric deliveries with concurrent CKD in the United States. Am J Kidney Dis. 2020;75(1):148–150. DOI: 10.1053/j.ajkd.2019.07.007

[94] Oliverio A.L., Admon L.K., Mariani L.H., et al. Health outcomes and health care utilization among obstetric deliveries with concurrent CKD in the United States // Am. J. Kidney Dis. 2020. Vol. 75. No. 1. P. 148–150. DOI: 10.1053/j.ajkd.2019.07.007

[95] Hladunewich MA, Hou S, Odutayo A, et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J Am Soc Nephrol. 2014;25(5):1103–1109. DOI: 10.1681/ASN.2013080825

[96] Hladunewich M.A., Hou S., Odutayo A., et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison // J. Am. Soc. Nephrol. 2014 Vol. 25. No. 5. P. 1103–1109. DOI: 10.1681/ASN.2013080825

[97] Piccoli GB, Minelli F, Versino E, et al. Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes. Nephrol Dial Transplant. 2015;31(11):1905–1934. DOI: 10.1093/ndt/gfv395

[98] Piccoli G.B., Minelli F., Versino E., et al. Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes // Nephrol. Dial. Transplant. 2015. Vol. 31. No. 11. P. 1905–1934. DOI: 10.1093/ndt/gfv395

[99] Tangren J, Nadel M, Hladunewich MA. Pregnancy and endstage renal disease. Blood Purif. 2018;45:(1)194–200. DOI: 10.1159/000485157

[100] Tangren J., Nadel M., Hladunewich M.A. Pregnancy and endstage renal disease // Blood Purif. 2018. Vol. 45. No. 1. P. 194–200. DOI: 10.1159/000485157

[101] Kothari M, Hampton TD, Singh M. Dialysis and pregnancy — a review. In J Nephrol Kidney Fail. 2019;5(2):1–7. DOI: 10.16966/ 2380-5498.175

[102] Kothari M., Hampton T.D., Singh M. Dialysis and pregnancy — a review // Int. J. Nephrol. Kidney Fail. 2019. Vol. 5. No. 2. P. 1–7. DOI: 10.16966/ 2380-5498.175

RIGHTS & PERMISSIONS

Grigoryeva O.A., Bezhenar V.F.